NCT04158336 2026-03-18
A Study of Azenosertib (ZN-c3) in Participants With Solid Tumors
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Phase 1 Completed
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
BeOne Medicines
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Mabwell (Shanghai) Bioscience Co., Ltd.
Novartis
Biohaven Pharmaceuticals, Inc.
Chugai Pharmaceutical
Sichuan Huiyu Pharmaceutical Co., Ltd
Salubris Biotherapeutics Inc
Eisai Inc.
InxMed (Shanghai) Co., Ltd.